Glaxo Wellcome Production

Ukraine

All drugs from this manufacturer

  • BECLAFORT EVOHALER

    The drug is used for the long-term treatment of severe asthma in adults, as well as for patients who require systemic steroids to control bronchial asthma symptoms.

    Dosage form: aerosol, metered for inhalation

    Active substance Dosage
    beclometasone dipropionate 250 mcg/dose

    ATC: R03BA01

  • The drug is used for the treatment and prevention of influenza types A and B in adults and children aged 5 years and older.

    Dosage form: powder, inhalation, metered

    Active substance Dosage
    zanamivir 5 mg

    ATC: J05AH01

  • The drug is used for rapid bronchodilation (effect occurs in approximately 5 minutes) during airway obstruction. It is used to relieve asthma attacks (e.g., in bronchial asthma), as well as to prevent bronchospasm attacks caused by allergens or physical exertion.

    Dosage form: aerosol, metered for inhalation

    Active substance Dosage
    salbutamol 100 mcg

    ATC: R03AC02

  • The drug is used for the regular treatment of bronchial asthma (if other methods do not provide sufficient control) and for maintenance therapy in chronic obstructive pulmonary disease (COPD).

    Dosage form: powder, inhalation, metered

    Active substance Dosage
    salmeterol 50 mcg
    fluticasone propionate 100 mcg

    ATC: R03AK06

  • The drug is used for the regular treatment of bronchial asthma (if other methods do not provide sufficient control) and for maintenance therapy in chronic obstructive pulmonary disease (COPD).

    Dosage form: powder, inhalation, metered

    Active substance Dosage
    salmeterol 50 mcg/dose
    fluticasone 250 mcg/dose

    ATC: R03AK06

  • The drug is used for the regular treatment of bronchial asthma and maintenance therapy for chronic obstructive pulmonary disease (COPD).

    Dosage form: powder, inhalation, metered

    Active substance Dosage
    salmeterol 50 mcg/dose
    fluticasone 500 mcg/dose

    ATC: R03AK06

  • The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy (a combination of a long-acting bronchodilator and an inhaled corticosteroid).

    Dosage form: aerosol, metered for inhalation

    Active substance Dosage
    salmeterol 25 mcg per dose
    fluticasone 50 mcg/dose

    ATC: R03AK06

  • The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy (a combination of a long-acting bronchodilator and an inhaled corticosteroid).

    Dosage form: aerosol, metered for inhalation

    Active substance Dosage
    salmeterol 25 mcg
    fluticasone 250 mcg

    ATC: R03AK06

  • The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy (a combination of a long-acting bronchodilator and an inhaled corticosteroid).

    Dosage form: aerosol, metered for inhalation

    Active substance Dosage
    salmeterol 25 mcg
    fluticasone propionate 125 mcg

    ATC: R03AK06